AMA survey shows 94% MD report delays in Pt care assoc w/ prior authorization. MDs spend 2d/wk on PA &1/3 hire added staff for PA. 4/5 PAs result in abandoned Rx. CMC has a proposed rule to speed up PA approval. Congress needs to act on this PA problem! https://t.co/XNtlk5TzX5 https://t.co/QtzXQLyjWD

Steroid-Sparing Rituximab in Polymyalgia Rheumatica https://t.co/FDvVSFnuDf https://t.co/s6B2AZrv1T

Dutch Biologic Monitor surveys of RA, PsA, axSpA pts on etanercept or adalimumab, looked at adverse drug reactions. Among 748 consecutive pts on biologics, women had more ADRs (55%) than men (38%). nature ofreported ADRs differed betw sexes (p = 0.02). https://t.co/fGRgX4IJLR https://t.co/FJE7BrKPfQ

Our next Tuesday Night Rheumatology addresses Contract Negotiations, featuring Andrea Liberatore, JD, Gwenesta Melton, MD, and Kathryn Dao, MD. Sign up to attend this and all of our Tuesday Night Rheumatology series. @uptoTate @KDAO2011 https://t.co/OuUnPnknQT https://t.co/fpNgGsnmb7

Disordered Pain Processing in Fibromyalgia A study provides evidence that certain brain areas involved in processing pain don’t function normally in fibromyalgia patients. https://t.co/oSrR0kEI7p https://t.co/0XGcvlbd3M

Analysis of 886 SpA pts in the Ankylosing Spondylitis Registry of Ireland shows women have worse BASDAI (4.57 vs 3.83, p < 0.01) & ASQoL (7.51 vs 6.12, p < 0.01) scores than males. higher scores in females due to all 6 BASDAI components https://t.co/2kt6t9MXUB https://t.co/o056cgF43V

Pooled data from 3 RCTs in PsA compared tofacitinib vs. adalimumab in 816 pts. Baseline, women had higher TJC, enthesitis, HAQ-DI, FACIT-F (Males more dactylitis). Sexes had equal ACR20/50/70, PASI75, ∆HAQ-DI, & persistence, but females less achieved MDA https://t.co/LICWVjI2kH https://t.co/8RipVIEWyJ

British Society of Rheumatology Plans Revision of Systemic Sclerosis Guideline BSR last published its guideline for SSc in 2016. Given the many advances in the field the BSR has outlined their plans to update the management of SSc. https://t.co/AlMOamGV5y https://t.co/d9RtWE4s0S

Our next Tuesday Night Rheumatology addresses Contract Negotiations, featuring Andrea Liberatore, JD, Gwenesta Melton, MD, and Kathryn Dao, MD. Sign up to attend this and all of our Tuesday Night Rheumatology series. @uptoTate @KDAO2011 https://t.co/z03KKCMpzE https://t.co/h6auLqwaE7

Inflammasome inhibitors in development: - RRx-001 in cancer, ALS, parkinsons - OLT1177 in OA knee, gout, Schnitzlers - DFV890 in CAPs, knee OA - IZD174/334 in CAPS - ZYIL1 CAPS https://t.co/7E2jdx9TPA https://t.co/R5Uu5mjIym

US MD survey shows # active MDs grew 33% to 923 419 (2001-2021). But AVG weekly work hrs declined 7.6% (53 to 49 hrs/wk). Decline driven by MD males/Fathers (-12%), rural MDs, 45-54 yrs old MDs. Only MD mothers had signif. increase in work hours (+3%) https://t.co/1CR2ERPX5e https://t.co/at0RJpcTEp

962 #RA pts from Leiden early arthritis clinic shows that in 2005 was a significant delay (~5wks) in referral of females vs male pts. The longer referral delays in female pts has since been eliminated. By 2020 the referral delay is same 4.7 vs 5.4 wks. https://t.co/JphiWWk85j https://t.co/bEHKLot4hu